Amberstone Biosciences is an emerging biotherapeutics company developing novel class of targeted and conditionally active immunotherapeutics to treat solid tumor cancers and other diseases. Amberstone Biosciences’ pipeline is driven by an innovative high-throughput functional discovery platform and strong expertise in an interdisciplinary field of biology, engineering, and therapeutic development.

‍